1 month ago
Fenimore ***** et Management, an investment management company, released its Q2 2026 investor letter. The letter can be downloaded here. U.S. equity markets saw broad gains in Q2, driven by strong corporate earnings, economic resilience, and enthusiasm for artificial intelligence (AI). Major indices reached all-time highs, though the energy sector declined. Continued earnings growth, especially among AI-related investments, supported the rally. Technology, particularly semiconductors, led performance as demand for AI infrastructure surged. Despite macroeconomic uncertainties and interest rate influences, Fenimore remains committed to investing in high-quality businesses. The Fenimore Small Cap Strategy returned 9.51% in the quarter, lagging the Russell 2000 Index's 21.49% gain. The underperformance was largely driven by avoiding lower-quality tech stocks linked to data center expansions. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Fenimore ***** et Management highlighted Ryan Specialty Holdings, Inc. (NYSE:RYAN). Ryan Specialty Holdings, Inc. (NYSE:RYAN) is a specialty insurance services company that provides distribution, underwriting, product development, administration, and risk management services. On September 17, 2026, Ryan Specialty Holdings, Inc. (NYSE:RYAN) closed at $40.03 per share. The one-month return of Ryan Specialty Holdings, Inc. (NYSE:RYAN) was -8.32%, and its shares lost 25.53% over the past 52 weeks. Ryan Specialty Holdings, Inc. (NYSE:RYAN) has a market capitalization of $10.15 billion.
Fenimore ***** et Management stated the following regarding Ryan Specialty Holdings, Inc. (NYSE:RYAN) in its Q2 2026 investor letter:
"We initiated a position in Ryan Specialty Holdings, Inc. (NYSE:RYAN), which we had previously owned after its initial public offering. The insurance industry has seen softness in rates. While RYAN's model differs from traditional retail brokerage, the company released results citing a volatile environment which led to a decrease in their earnings outlook for the year. We're encouraged by the business's long-term prospects and, in our opinion, its legendary leader Pat Ryan. He is also purchasing shares of RYAN's stock during this weakness."
Ryan Specialty Holdings, Inc. (NYSE:RYAN) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 32 hedge fund portfolios held Ryan Specialty Holdings, Inc. (NYSE:RYAN) at the end of the second quarter, compared to 35 in the previous quarter. While we acknowledge the potential of Ryan Specialty Holdings, Inc. (NYSE:RYAN) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
In its second-quarter 2026 investor letter, Fenimore ***** et Management highlighted Ryan Specialty Holdings, Inc. (NYSE:RYAN). Ryan Specialty Holdings, Inc. (NYSE:RYAN) is a specialty insurance services company that provides distribution, underwriting, product development, administration, and risk management services. On September 17, 2026, Ryan Specialty Holdings, Inc. (NYSE:RYAN) closed at $40.03 per share. The one-month return of Ryan Specialty Holdings, Inc. (NYSE:RYAN) was -8.32%, and its shares lost 25.53% over the past 52 weeks. Ryan Specialty Holdings, Inc. (NYSE:RYAN) has a market capitalization of $10.15 billion.
Fenimore ***** et Management stated the following regarding Ryan Specialty Holdings, Inc. (NYSE:RYAN) in its Q2 2026 investor letter:
"We initiated a position in Ryan Specialty Holdings, Inc. (NYSE:RYAN), which we had previously owned after its initial public offering. The insurance industry has seen softness in rates. While RYAN's model differs from traditional retail brokerage, the company released results citing a volatile environment which led to a decrease in their earnings outlook for the year. We're encouraged by the business's long-term prospects and, in our opinion, its legendary leader Pat Ryan. He is also purchasing shares of RYAN's stock during this weakness."
Ryan Specialty Holdings, Inc. (NYSE:RYAN) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 32 hedge fund portfolios held Ryan Specialty Holdings, Inc. (NYSE:RYAN) at the end of the second quarter, compared to 35 in the previous quarter. While we acknowledge the potential of Ryan Specialty Holdings, Inc. (NYSE:RYAN) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
2 months ago
The Atlanta Braves are making moves as September roster expansions approach. Atlanta has added right-handed relief pitcher Blake Burkhalter and veteran infielder Kyle Farmer to the active roster ahead of Tuesday's game against the Washington Nationals.
Burkhalter earns his long-awaited big-league debut after a stellar minor-league season. The 25-year-old has posted a 1.26 ERA with 46 strikeouts and a 1.12 WHIP across 35 2/3 innings in 26 appearances in relief this year.
MORE: Braves finally demote struggling hitter after Brewers series
Farmer is a nine-year big-league veteran who has already spent time with Atlanta earlier this season and brings bench depth. Across 15 games he has posted a .267 batting average, .250 on-base percentage and .583 OPS.
To clear a 40-man roster spot, the Braves transferred right-hander Robert Suarez to the 60-day injured list as he continues working back from right elbow inflammation. The move is procedural and keeps Suarez on the roster without requiring a waiver designation. His placement was backdated to when he first suffered the injury in June. When healthy this season, Suarez was outstanding, posting a 0.56 ERA with 26 strikeouts and four saves across 32 innings.
#right #burkhalter
Burkhalter earns his long-awaited big-league debut after a stellar minor-league season. The 25-year-old has posted a 1.26 ERA with 46 strikeouts and a 1.12 WHIP across 35 2/3 innings in 26 appearances in relief this year.
MORE: Braves finally demote struggling hitter after Brewers series
Farmer is a nine-year big-league veteran who has already spent time with Atlanta earlier this season and brings bench depth. Across 15 games he has posted a .267 batting average, .250 on-base percentage and .583 OPS.
To clear a 40-man roster spot, the Braves transferred right-hander Robert Suarez to the 60-day injured list as he continues working back from right elbow inflammation. The move is procedural and keeps Suarez on the roster without requiring a waiver designation. His placement was backdated to when he first suffered the injury in June. When healthy this season, Suarez was outstanding, posting a 0.56 ERA with 26 strikeouts and four saves across 32 innings.
#right #burkhalter
2 months ago
On August 4, Archer-Daniels-Midland (NYSE:ADM) executives told investors on an earnings call that the company would expand capacity at four US oilseed-crushing plants, a roughly $100 million push into a business that just posted its strongest quarter in years. The plants sit in Frankfort, Indiana; Deerfield, Missouri; Lincoln, Nebraska; and Spiritwood, North Dakota, the last a joint venture with Marathon Petroleum. Together, the upgrades are expected to add about 700,000 metric tons of crush capacity by 2028 or 2029, and six more sites have already been flagged for possible future growth.
CEO Juan Luciano framed the projects as a cheap way to add output, estimating the cost at roughly a quarter of what a brand-new facility would require. That math matters because ADM just reported second-quarter adjusted earnings per share of $1.84, well above the $1.44 ***** ysts expected, and raised its full-year 2026 adjusted EPS guidance to a range of $5.15 to $5.60 from a prior $4.15 to $4.70. Operating profit in the ag services and oilseeds segment, ADM's largest, jumped 129% year over year to $867 million, with the crushing subsegment alone up $330 million as oilseed volumes climbed about 5%.
The company has now identified 10 US soy processing plants for potential expansion in total, and Luciano said top buyer China appears on track to meet its commitment to purchase 25 million metric tons of US soybeans this year. Nutrition, long a laggard, also grew 51% to $172 million on strength in flavors. Even so, Luciano described the crushing expansion as a "phased approach to allow for offramps," language that suggests management wants room to pull back if the current environment does not hold. The projects are expected to fit inside ADM's existing 2026 capital expenditure range of $1.3 billion to $1.5 billion, following expansions at two Brazilian plants last year and an extension completed this year in Uberlandia.
The strength behind these numbers leans heavily on conditions ADM does not control. Finalized 2026 and 2027 renewable volume obligations under the US Renewable Fuel Standard, locked in only this past March, are doing much of the work behind crushing margins, alongside energy prices that climbed after the Iran war. Roughly $100 million of the ag services and oilseeds profit came from net positive mark-to-market and timing impacts, gains tied to commodity pricing swings rather than the underlying business.
Not every part of the portfolio moved in the same direction. The refined products and other subsegment posted a 3% profit decline on negative mark-to-market impacts and supply and demand imbalances in South America, and equity earnings from ADM's stake in Wilmar fell 22%. Those soft spots, paired with a crush expansion built with explicit offramps, hint that management sees more uncertainty in the setup than the headline guidance raise suggests.
#luciano #quarter #expected
CEO Juan Luciano framed the projects as a cheap way to add output, estimating the cost at roughly a quarter of what a brand-new facility would require. That math matters because ADM just reported second-quarter adjusted earnings per share of $1.84, well above the $1.44 ***** ysts expected, and raised its full-year 2026 adjusted EPS guidance to a range of $5.15 to $5.60 from a prior $4.15 to $4.70. Operating profit in the ag services and oilseeds segment, ADM's largest, jumped 129% year over year to $867 million, with the crushing subsegment alone up $330 million as oilseed volumes climbed about 5%.
The company has now identified 10 US soy processing plants for potential expansion in total, and Luciano said top buyer China appears on track to meet its commitment to purchase 25 million metric tons of US soybeans this year. Nutrition, long a laggard, also grew 51% to $172 million on strength in flavors. Even so, Luciano described the crushing expansion as a "phased approach to allow for offramps," language that suggests management wants room to pull back if the current environment does not hold. The projects are expected to fit inside ADM's existing 2026 capital expenditure range of $1.3 billion to $1.5 billion, following expansions at two Brazilian plants last year and an extension completed this year in Uberlandia.
The strength behind these numbers leans heavily on conditions ADM does not control. Finalized 2026 and 2027 renewable volume obligations under the US Renewable Fuel Standard, locked in only this past March, are doing much of the work behind crushing margins, alongside energy prices that climbed after the Iran war. Roughly $100 million of the ag services and oilseeds profit came from net positive mark-to-market and timing impacts, gains tied to commodity pricing swings rather than the underlying business.
Not every part of the portfolio moved in the same direction. The refined products and other subsegment posted a 3% profit decline on negative mark-to-market impacts and supply and demand imbalances in South America, and equity earnings from ADM's stake in Wilmar fell 22%. Those soft spots, paired with a crush expansion built with explicit offramps, hint that management sees more uncertainty in the setup than the headline guidance raise suggests.
#luciano #quarter #expected
2 months ago
The on-demand library it was built on is no longer the story management leads with, and the quality measure it now sets beside view hours is one the company will not detail.
Netflix (NFLX) has fallen 34.4% over the past twelve months while the S&P 500 returned 21.0%, though it is still 18.1% higher than it was twenty-four months ago. The bigger change is not in the price: the company has moved its lead story off the on-demand library it was built on and the quality side of its engagement case out of public view.
Management Used To Describe The Company Narrowly
In earlier calls management described the company narrowly: it was in the subscription entertainment business, and its core strategy was giving members exclusive first-run movies. That is no longer the whole of it. In the July 2026 call management says the definition of TV has broadened and its own has changed with it. The core TV series and film still take the vast majority of programming spend; what management foregrounds alongside them is live programming, cloud games, video podcasts, and carrying content partner TF1's local programming inside Netflix for French members. Management itself calls the expansions evolutionary rather than revolutionary.
Five Percent Of Spend, One Percent Of Hours
#percent
Netflix (NFLX) has fallen 34.4% over the past twelve months while the S&P 500 returned 21.0%, though it is still 18.1% higher than it was twenty-four months ago. The bigger change is not in the price: the company has moved its lead story off the on-demand library it was built on and the quality side of its engagement case out of public view.
Management Used To Describe The Company Narrowly
In earlier calls management described the company narrowly: it was in the subscription entertainment business, and its core strategy was giving members exclusive first-run movies. That is no longer the whole of it. In the July 2026 call management says the definition of TV has broadened and its own has changed with it. The core TV series and film still take the vast majority of programming spend; what management foregrounds alongside them is live programming, cloud games, video podcasts, and carrying content partner TF1's local programming inside Netflix for French members. Management itself calls the expansions evolutionary rather than revolutionary.
Five Percent Of Spend, One Percent Of Hours
#percent
2 months ago
By Amanda Stephenson and Arathy Somasekhar
CALGARY, Aug 18 (Reuters) - Canadian pipeline firms are proposing billions of dollars in new projects despite oil sands companies being reluctant to commit to significant production expansions amid ongoing uncertainty around climate policies and long-term global demand.
At least six different pipeline projects are underway or proposed in Canada, to move oil to the United States or to export markets on the Pacific coast. If all are built, the country's export pipeline capacity would increase by 45%, or 2.25 million barrels per day, by 2035, according to a Reuters calculation.
But filling all those pipes would require Canadian oil supply to increase by more than a third by 2034, a near-doubling of its current annual average growth rate. It would also require Canadian producers to move ahead with major new oil sands projects of the type that no company has undertaken in more than a decade.
The mismatch between proposed export pipeline expansions and the pace of output growth highlights how Canada may struggle to achieve Prime Minister Mark Carney's "energy superpower" ambitions, despite a more supportive regulatory environment and growing interest in Canadian oil from international buyers.
#canadian #despite #expansions
CALGARY, Aug 18 (Reuters) - Canadian pipeline firms are proposing billions of dollars in new projects despite oil sands companies being reluctant to commit to significant production expansions amid ongoing uncertainty around climate policies and long-term global demand.
At least six different pipeline projects are underway or proposed in Canada, to move oil to the United States or to export markets on the Pacific coast. If all are built, the country's export pipeline capacity would increase by 45%, or 2.25 million barrels per day, by 2035, according to a Reuters calculation.
But filling all those pipes would require Canadian oil supply to increase by more than a third by 2034, a near-doubling of its current annual average growth rate. It would also require Canadian producers to move ahead with major new oil sands projects of the type that no company has undertaken in more than a decade.
The mismatch between proposed export pipeline expansions and the pace of output growth highlights how Canada may struggle to achieve Prime Minister Mark Carney's "energy superpower" ambitions, despite a more supportive regulatory environment and growing interest in Canadian oil from international buyers.
#canadian #despite #expansions
3 months ago
It was reported on July 27 that AstraZeneca PLC (NASDAQ:AZN) shares outperformed in European trading after the company reported second-quarter earnings that beat Wall Street expectations and reiterated its full-year 2026 guidance. Core earnings per share (EPS) jumped 18% on a constant exchange rate (FXN) basis year-over-year to $2.63, comfortably ahead of the $2.48 ***** yst consensus. Total revenue reached $15.38 billion, up 5% at constant exchange rates, driven primarily by sustained momentum in its Oncology and Rare Disease units. Management reconfirmed its full-year 2026 outlook of mid-to-high single-digit revenue growth and low double-digit Core EPS growth, expressing confidence in reaching its $80 billion total revenue target by 2030 despite near-term headwind shocks.
The quarter demonstrated strong commercial execution in core growth engines. Oncology revenue rose 16% to $7.33 billion, supported by strong demand for Tagrisso ($1.94 billion), Imfinzi ($1.85 billion), and Enhertu (+31%). Rare Disease contributed $4.9 billion, led by Ultomiris. These gains successfully offset severe pressures in the Cardiovascular, Renal & Metabolism (CVRM) segment, which declined 15% due to the loss of exclusivity (LOE) for Farxiga in the U.S. and ongoing Volume-Based Procurement (VBP) price cuts in China.
Meanwhile, pipeline updates presented a mixed picture. On July 27, AZN disclosed that a Phase 3 study evaluating Ultomiris in hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) failed to hit its primary endpoint of event-free survival at week 26 versus placebo. Following the readout, H.C. Wainwright noted that the trial miss represents a "clear positive" for competitor Omeros (OMER), removing a major near-term competitive overhang on its drug Yartemlea and driving Omeros shares up 11% in morning trading.
AstraZeneca PLC (NASDAQ:AZN)'s core profitability remains elite, with core operating margins expanding to 34% in Q2 despite top-line headwinds from generic entry. High gross and net margins signal durable pricing power across its branded specialty portfolio. This strong profitability generates predictable cash flow to fund heavy R&D investments, commercial rollouts, and growing shareholder returns, including a 3-cent increase in the interim dividend to $1.06 per share, while buffering the company against pricing pressure.
The company's expansive late-stage pipeline and high volume of regulatory approvals underpin a multi-year growth trajectory. With 30 major regional approvals since late 2025 and more than 20 high-value trial readouts scheduled over the next 18 months, AZN possesses broad commercial optionality. Continued expansions in oncology (e.g., Enhertu and Imfinzi) and respiratory therapies (such as Breztri and Tezspire) provide direct revenue replacement for legacy products facing patent expiration.
#high #july
The quarter demonstrated strong commercial execution in core growth engines. Oncology revenue rose 16% to $7.33 billion, supported by strong demand for Tagrisso ($1.94 billion), Imfinzi ($1.85 billion), and Enhertu (+31%). Rare Disease contributed $4.9 billion, led by Ultomiris. These gains successfully offset severe pressures in the Cardiovascular, Renal & Metabolism (CVRM) segment, which declined 15% due to the loss of exclusivity (LOE) for Farxiga in the U.S. and ongoing Volume-Based Procurement (VBP) price cuts in China.
Meanwhile, pipeline updates presented a mixed picture. On July 27, AZN disclosed that a Phase 3 study evaluating Ultomiris in hematopoietic stem cell transplant-associated thrombotic microangiopathy (HSCT-TMA) failed to hit its primary endpoint of event-free survival at week 26 versus placebo. Following the readout, H.C. Wainwright noted that the trial miss represents a "clear positive" for competitor Omeros (OMER), removing a major near-term competitive overhang on its drug Yartemlea and driving Omeros shares up 11% in morning trading.
AstraZeneca PLC (NASDAQ:AZN)'s core profitability remains elite, with core operating margins expanding to 34% in Q2 despite top-line headwinds from generic entry. High gross and net margins signal durable pricing power across its branded specialty portfolio. This strong profitability generates predictable cash flow to fund heavy R&D investments, commercial rollouts, and growing shareholder returns, including a 3-cent increase in the interim dividend to $1.06 per share, while buffering the company against pricing pressure.
The company's expansive late-stage pipeline and high volume of regulatory approvals underpin a multi-year growth trajectory. With 30 major regional approvals since late 2025 and more than 20 high-value trial readouts scheduled over the next 18 months, AZN possesses broad commercial optionality. Continued expansions in oncology (e.g., Enhertu and Imfinzi) and respiratory therapies (such as Breztri and Tezspire) provide direct revenue replacement for legacy products facing patent expiration.
#high #july
3 months ago
Interested in Louisiana-Pacific Corporation? Here are five stocks we like better.
Second-quarter results weakened: Sales fell $90 million year over year to $664 million and EBITDA dropped $63 million to $79 million, primarily because of lower OSB prices and volumes. LP expects OSB EBITDA of approximately negative $45 million in Q3 and negative $120 million for 2026 if prices remain flat.
Siding showed resilience and is expected to rebound: Despite a 4% sales decline and weather, freight and inflation disruptions, the segment maintained a 26% EBITDA margin. LP forecasts Q3 Siding revenue of $460 million–$470 million and EBITDA of $110 million–$120 million, with modest volume growth anticipated.
LP is prioritizing Siding investment while reducing spending elsewhere: The company cut its 2026 capital-expenditure outlook by $70 million to about $320 million, largely by delaying OSB maintenance projects, while directing roughly three-quarters of spending toward Siding capacity expansions.
These 3 Rising Dividend Plays Come Cheap
#negative
Second-quarter results weakened: Sales fell $90 million year over year to $664 million and EBITDA dropped $63 million to $79 million, primarily because of lower OSB prices and volumes. LP expects OSB EBITDA of approximately negative $45 million in Q3 and negative $120 million for 2026 if prices remain flat.
Siding showed resilience and is expected to rebound: Despite a 4% sales decline and weather, freight and inflation disruptions, the segment maintained a 26% EBITDA margin. LP forecasts Q3 Siding revenue of $460 million–$470 million and EBITDA of $110 million–$120 million, with modest volume growth anticipated.
LP is prioritizing Siding investment while reducing spending elsewhere: The company cut its 2026 capital-expenditure outlook by $70 million to about $320 million, largely by delaying OSB maintenance projects, while directing roughly three-quarters of spending toward Siding capacity expansions.
These 3 Rising Dividend Plays Come Cheap
#negative
3 months ago
Our ****** ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Turns out the safest bet in toys right now isn't a toy at all. It's a piece of cardboard with a cartoon monster on it. Asmodee just proved that trading cards are quietly the best business in the building, better margins, more heat, more staying power than anything with a board and a rulebook attached. Investors bought in for CATAN. They're staying for the booster packs.
Asmodee shares jumped to a record high after a first-quarter earnings beat that had Pokémon doing most of the heavy lifting.
Net sales rose 20.9% to €422.1 million (about $486.2 million), ahead of expectations near €404 million, with organic growth just over 20%, meaning this wasn't acquisitions doing the work. Trading card games led the way, up 23.1% to €285 million on demand for Pokémon, Magic: The Gathering, Yu-Gi-Oh, One Piece and a run of newer ****** les. Board games grew 16% to €103 million, helped by evergreen franchises like CATAN and Dobble, new releases and expansions, plus a contribution from recently acquired ATM Gaming.
Profitability outran sales. Adjusted EBITDA climbed 55% to €61.9 million from €39.9 million, and the margin expanded to 14.7% from 11.4%. EBIT rose to €40.5 million, and profit attributable to shareholders swung to €17 million from a €1.6 million loss a year earlier. Shares rose as much as 10% on the news.
#trading
Turns out the safest bet in toys right now isn't a toy at all. It's a piece of cardboard with a cartoon monster on it. Asmodee just proved that trading cards are quietly the best business in the building, better margins, more heat, more staying power than anything with a board and a rulebook attached. Investors bought in for CATAN. They're staying for the booster packs.
Asmodee shares jumped to a record high after a first-quarter earnings beat that had Pokémon doing most of the heavy lifting.
Net sales rose 20.9% to €422.1 million (about $486.2 million), ahead of expectations near €404 million, with organic growth just over 20%, meaning this wasn't acquisitions doing the work. Trading card games led the way, up 23.1% to €285 million on demand for Pokémon, Magic: The Gathering, Yu-Gi-Oh, One Piece and a run of newer ****** les. Board games grew 16% to €103 million, helped by evergreen franchises like CATAN and Dobble, new releases and expansions, plus a contribution from recently acquired ATM Gaming.
Profitability outran sales. Adjusted EBITDA climbed 55% to €61.9 million from €39.9 million, and the margin expanded to 14.7% from 11.4%. EBIT rose to €40.5 million, and profit attributable to shareholders swung to €17 million from a €1.6 million loss a year earlier. Shares rose as much as 10% on the news.
#trading
3 months ago
I have a history with Bloom Energy (NYSE: BE) stock. I have long been a believer in its fuel cell technology, and initially bought the stock in 2020 for $18.50 per share. Fast-forward to the artificial intelligence (AI) data center boom, and interest in its products exploded.
Bloom shares went parabolic and finished 2025 with a 291% annual gain. That continued into this year with Bloom's market cap peaking at nearly $100 billion. That's after the company reported just $2 billion in revenue for 2025.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
That was all too much, too fast for me. I sold call options with a strike price of just $60, and after several rounds rolling them out, my shares were called away. That was acceptable to me, as I didn't believe the underlying business was quite worthy of all the AI hype.
While management was announcing plans for capacity expansions, it would take significantly more revenue to justify the market valuation. Now shares are well off their peak, though.
#billion
Bloom shares went parabolic and finished 2025 with a 291% annual gain. That continued into this year with Bloom's market cap peaking at nearly $100 billion. That's after the company reported just $2 billion in revenue for 2025.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
That was all too much, too fast for me. I sold call options with a strike price of just $60, and after several rounds rolling them out, my shares were called away. That was acceptable to me, as I didn't believe the underlying business was quite worthy of all the AI hype.
While management was announcing plans for capacity expansions, it would take significantly more revenue to justify the market valuation. Now shares are well off their peak, though.
#billion
3 months ago
Our ******* ysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here.
Enterprise organic bookings surged 37%, resulting in a record $12.1 billion backlog that provides high visibility into revenue acceleration for the second half of 2026 and into 2027.
The Americas Commercial HVAC segment achieved exceptional bookings growth of 50%, with all 14 key verticals growing by over 20% during the quarter., with particular strength in data centers.
Applied bookings grew over 100% for the fourth consecutive quarter, reflecting a fourfold increase on a two-year stack as customers prioritize energy-efficient thermal management systems.
Management attributed margin performance to intentional, heavy reinvestment in capacity expansions, innovation, and the deployment of the business operating system into recent acquisitions like Stellar.
#enterprise #americas #hvac
Enterprise organic bookings surged 37%, resulting in a record $12.1 billion backlog that provides high visibility into revenue acceleration for the second half of 2026 and into 2027.
The Americas Commercial HVAC segment achieved exceptional bookings growth of 50%, with all 14 key verticals growing by over 20% during the quarter., with particular strength in data centers.
Applied bookings grew over 100% for the fourth consecutive quarter, reflecting a fourfold increase on a two-year stack as customers prioritize energy-efficient thermal management systems.
Management attributed margin performance to intentional, heavy reinvestment in capacity expansions, innovation, and the deployment of the business operating system into recent acquisitions like Stellar.
#enterprise #americas #hvac
3 months ago
Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, the role AI is playing in it. To get this in your inbox, sign up here for free — just click TechCrunch Mobility!
Tesla kicked off earnings season — at least for this sector — and the shareholder letter, along with Elon Musk's remarks during the conference call, provided some pretty incredible disclosures I imagine have some investors concerned, or at least puzzled.
Tesla has backed off previous promises to reach "volume production" of the Cybercab, Tesla Semi, and Megapack 3 in 2026. And while the company has publicly touted expansions of its Tesla Robotaxi service into new cities in Florida and Texas, the quarter-over-quarter data shows a drop in paid robotaxi miles.
Senior reporter Sean O'Kane took a closer look at a graph shared in Tesla's shareholder letter. At a passing glance, the chart appears to show steady growth in paid robotaxi rides between August 2025 and June 2026, O'Kane notes. But the numbers displayed are **** ulative, and when broken down by quarter, they show that Tesla's Robotaxi fleet of Model Y SUVs carrying paying passengers covered around 1.1 million miles in the first quarter. That fell to roughly 700,000 miles in the second quarter, a decline of about 36%.
Musk also disclosed during the call that Tesla needs to accumulate driving data specific to the Cybercab before it can put large numbers of the vehicles on the road. That isn't terribly surprising; the Cybercab is new, after all. But the reason got my attention. He explained that Tesla has to accumulate miles using Cybercabs retrofitted with steering wheels and accelerator and braking pedals so it can calibrate to the Cybercab chassis.
#robotaxi
Tesla kicked off earnings season — at least for this sector — and the shareholder letter, along with Elon Musk's remarks during the conference call, provided some pretty incredible disclosures I imagine have some investors concerned, or at least puzzled.
Tesla has backed off previous promises to reach "volume production" of the Cybercab, Tesla Semi, and Megapack 3 in 2026. And while the company has publicly touted expansions of its Tesla Robotaxi service into new cities in Florida and Texas, the quarter-over-quarter data shows a drop in paid robotaxi miles.
Senior reporter Sean O'Kane took a closer look at a graph shared in Tesla's shareholder letter. At a passing glance, the chart appears to show steady growth in paid robotaxi rides between August 2025 and June 2026, O'Kane notes. But the numbers displayed are **** ulative, and when broken down by quarter, they show that Tesla's Robotaxi fleet of Model Y SUVs carrying paying passengers covered around 1.1 million miles in the first quarter. That fell to roughly 700,000 miles in the second quarter, a decline of about 36%.
Musk also disclosed during the call that Tesla needs to accumulate driving data specific to the Cybercab before it can put large numbers of the vehicles on the road. That isn't terribly surprising; the Cybercab is new, after all. But the reason got my attention. He explained that Tesla has to accumulate miles using Cybercabs retrofitted with steering wheels and accelerator and braking pedals so it can calibrate to the Cybercab chassis.
#robotaxi
3 months ago
We can separate high-yield dividend stocks into two broad categories. The first group consists of companies with stable businesses that generate consistent cash flow and are very likely to continue paying -- and perhaps raising -- their dividends for the foreseeable future. The second are distressed corporations. They boast high yields because their share prices have fallen substantially, reflecting weak business fundamentals.
Many investors would put Pfizer (NYSE: PFE) in the second group. The drugmaker's shares have lost significant value over the past five years, as the company has failed to sustain the amazing success it achieved in the coronavirus market. However, there is much more to the story. Let's discuss why Pfizer's 7% forward yield is more sustainable than it appears at first glance.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Pfizer's revenue and earnings have declined over the past five years, while it has maintained and even increased its dividend. The company's payout ratio has soared as a result -- it is currently about 127%. That looks unsustainable. But Pfizer's cash payout ratio, a much better measure of whether the company can maintain its dividend program intact, looks less scary at 107.7%. Management is confident of the company's ability to sustain, and even increase, the payout moving forward. That isn't just wishful thinking: Pfizer could improve its business in the coming years and eventually post much stronger financial results.
Consider that Pfizer boasts highly promising programs in the pipeline that will yield brand-new approvals and label expansions. For instance, the company's Padcev is a cancer medicine that is currently one of its better-performing products. On July 10, Padcev earned approval for the treatment of muscle-invasive bladder cancer in combination with Merck's (NYSE: MRK) Keytruda. Padcev was granted the green light regardless of whether patients are eligible for Cisplatin, a chemotherapy drug for bladder cancer that is effective but comes with significant side effects. That's a big deal since many drugs for bladder cancer (including Padcev, initially) aren't approved regardless of Cisplatin eligibility.
#NVIDIA #yield #first
Many investors would put Pfizer (NYSE: PFE) in the second group. The drugmaker's shares have lost significant value over the past five years, as the company has failed to sustain the amazing success it achieved in the coronavirus market. However, there is much more to the story. Let's discuss why Pfizer's 7% forward yield is more sustainable than it appears at first glance.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Pfizer's revenue and earnings have declined over the past five years, while it has maintained and even increased its dividend. The company's payout ratio has soared as a result -- it is currently about 127%. That looks unsustainable. But Pfizer's cash payout ratio, a much better measure of whether the company can maintain its dividend program intact, looks less scary at 107.7%. Management is confident of the company's ability to sustain, and even increase, the payout moving forward. That isn't just wishful thinking: Pfizer could improve its business in the coming years and eventually post much stronger financial results.
Consider that Pfizer boasts highly promising programs in the pipeline that will yield brand-new approvals and label expansions. For instance, the company's Padcev is a cancer medicine that is currently one of its better-performing products. On July 10, Padcev earned approval for the treatment of muscle-invasive bladder cancer in combination with Merck's (NYSE: MRK) Keytruda. Padcev was granted the green light regardless of whether patients are eligible for Cisplatin, a chemotherapy drug for bladder cancer that is effective but comes with significant side effects. That's a big deal since many drugs for bladder cancer (including Padcev, initially) aren't approved regardless of Cisplatin eligibility.
#NVIDIA #yield #first
4 months ago
A repeat offender was charged with trespassing at Illinois Gov. JB Pritzker's Chicago home over Independence Day weekend, prompting renewed criticism from Republicans and crime-policy critics over the Democrat's public-safety record.
Dwayne Cortez Milton was arrested on the night of July 4 after he was seen allegedly jumping a fence and entering Pritzker's backyard. Milton faces a trespassing charge but was released from custody pending trial, Abc 7 Chicago reported.
Milton was ordered released in the trespassing case, but court documents show he pleaded guilty July 7 in a separate theft case and remains in custody. The suspect was allegedly under electronic monitoring at the time of the trespassing charge and had an extensive criminal history, CWB Chicago reported, citing court records.
Pritzker has been repeatedly criticized for his soft-on-crime policies, including the elimination of cash bail, opposition to mandatory minimum expansions, expanding parole opportunities and sentencing reform. Illinois became the first state to abolish cash bail statewide after Pritzker signed the SAFE-T Act in 2021, following years of Democratic-led criminal justice reform efforts in the state.
Reporter's Notebook: Chicago Cop Killed After Suspect Released Under Safe-t Act
Dwayne Cortez Milton was arrested on the night of July 4 after he was seen allegedly jumping a fence and entering Pritzker's backyard. Milton faces a trespassing charge but was released from custody pending trial, Abc 7 Chicago reported.
Milton was ordered released in the trespassing case, but court documents show he pleaded guilty July 7 in a separate theft case and remains in custody. The suspect was allegedly under electronic monitoring at the time of the trespassing charge and had an extensive criminal history, CWB Chicago reported, citing court records.
Pritzker has been repeatedly criticized for his soft-on-crime policies, including the elimination of cash bail, opposition to mandatory minimum expansions, expanding parole opportunities and sentencing reform. Illinois became the first state to abolish cash bail statewide after Pritzker signed the SAFE-T Act in 2021, following years of Democratic-led criminal justice reform efforts in the state.
Reporter's Notebook: Chicago Cop Killed After Suspect Released Under Safe-t Act
4 months ago
Vertex Pharmaceuticals (NASDAQ:VRTX) is one of the best QQQ Stocks to invest in. On July 1, Vertex Pharmaceuticals announced that the US FDA approved the expanded use of its genetic therapy, CASGEVY, to treat children as young as 2 years old. This makes it the first and only approved gene therapy for patients of this age range suffering from sickle cell disease or transfusion-dependent beta thalassemia.
This regulatory milestone makes approximately 5,500 additional children in the US eligible for the one-time treatment. By providing earlier access to the therapy, clinicians hope to address the progression of these life-shortening diseases before significant, irreversible organ damage occurs.
Vertex Pharmaceuticals (NASDAQ:VRTX) established a network of over 75 authorized treatment centers across the U.S. to manage patient access and care. While this approval is specific to the US market, the company noted that regulatory reviews for similar label expansions are currently underway in the UK and the Kingdom of Saudi Arabia.
Vertex Pharmaceuticals (NASDAQ:VRTX) operates as a biotechnology company in the US, Europe, and internationally.
While we acknowledge the potential of VRTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
This regulatory milestone makes approximately 5,500 additional children in the US eligible for the one-time treatment. By providing earlier access to the therapy, clinicians hope to address the progression of these life-shortening diseases before significant, irreversible organ damage occurs.
Vertex Pharmaceuticals (NASDAQ:VRTX) established a network of over 75 authorized treatment centers across the U.S. to manage patient access and care. While this approval is specific to the US market, the company noted that regulatory reviews for similar label expansions are currently underway in the UK and the Kingdom of Saudi Arabia.
Vertex Pharmaceuticals (NASDAQ:VRTX) operates as a biotechnology company in the US, Europe, and internationally.
While we acknowledge the potential of VRTX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
4 months ago
Golden Knights owner Bill Foley will take time away from his vacation to return to Las Vegas to attend portions of NBA Summer League. Foley, who has been in wine country in Northern California escaping the triple-digit Southern Nevada heat since the Knights were beaten by the Carolina Hurricanes in the Stanley Cup Final, will be in Las Vegas this week as he and his group are in the midst of a bid to land an NBA expansions team.
reviewjournal.com
This article originally appeared on Hoops Hype: Golden Knights owner Bill Foley will take time away …
reviewjournal.com
This article originally appeared on Hoops Hype: Golden Knights owner Bill Foley will take time away …
4 months ago
Silverstone doesn't have a bowl like Indianapolis, and Northamptonshire isn't exactly blessed with parking capacity. And yet 564,000 people found a way to cram themselves onto that old airfield between July 3 and July 5, the largest crowd that has ever turned out for a Formula 1 event anywhere on the calendar. That number doesn't describe one sunny afternoon. It's the ******* ulative count across practice, sprint qualifying, the sprint race, qualifying, and Sunday's Grand Prix, and it says more about where this sport is right now than any single lap time does.
Attendance figures like this one are always tallies, not single-day headcounts, and that distinction matters before anyone starts comparing it to a football stadium's capacity. A circuit can only physically hold so many bodies on race day itself once you account for grandstands, run-off, and emergency egress routes, so that number is effectively capped no matter how badly a promoter wants to sell more tickets. What made 2026 different wasn't a bigger track. It was hundreds of thousands of people deciding a Friday practice session and a Saturday sprint were worth paying for on top of Sunday, and that's really the figure that ought to have circuit marketing departments elsewhere paying attention.
We already broke down the race itself in detail, and it earned every one of those extra ticket sales. Charles Leclerc finally won at Silverstone after years of trying, Kimi Antonelli's ******* le bid came apart when a wheel shield failed while he was hunting down the lead, and Max Verstappen buried his Red Bull in the Stowe gravel for the second race weekend running because of the same rear wing fault that ended his qualifying in Austria. It was as chaotic as Silverstone has been in years, sprint format included, and the on-track drama only made the record crowd figure look better in hindsight.
The grid walk on Sunday looked less like a paddock and more like an awards-show red carpet, with Hannah Waddingham, Hugh Grant, Jeremy Clarkson, Brian May, and a rotating cast of Premier League footballers all wandering around before lights out. None of that happens by accident. It's the byproduct of a decade of deliberate positioning, Drive to Survive turning drivers into recognizable characters, Lewis Hamilton's move to Ferrari giving British fans a rooting interest wrapped in Italian red, and a championship fight tight enough that Antonelli, Russell, and Hamilton are now separated by 32 points with more than a third of the season still to run.
There's a financial angle to a record crowd that's easy to skip past amid the celebrity spotting. Grandstand seats, hospitality packages, and paddock club access make race week Silverstone's single biggest revenue event of the year, and promoters don't publish attendance totals purely for bragging rights. They're effectively an annual earnings report for the venue, one that circuits use internally to justify grandstand expansions and, eventually, to defend the nex
Attendance figures like this one are always tallies, not single-day headcounts, and that distinction matters before anyone starts comparing it to a football stadium's capacity. A circuit can only physically hold so many bodies on race day itself once you account for grandstands, run-off, and emergency egress routes, so that number is effectively capped no matter how badly a promoter wants to sell more tickets. What made 2026 different wasn't a bigger track. It was hundreds of thousands of people deciding a Friday practice session and a Saturday sprint were worth paying for on top of Sunday, and that's really the figure that ought to have circuit marketing departments elsewhere paying attention.
We already broke down the race itself in detail, and it earned every one of those extra ticket sales. Charles Leclerc finally won at Silverstone after years of trying, Kimi Antonelli's ******* le bid came apart when a wheel shield failed while he was hunting down the lead, and Max Verstappen buried his Red Bull in the Stowe gravel for the second race weekend running because of the same rear wing fault that ended his qualifying in Austria. It was as chaotic as Silverstone has been in years, sprint format included, and the on-track drama only made the record crowd figure look better in hindsight.
The grid walk on Sunday looked less like a paddock and more like an awards-show red carpet, with Hannah Waddingham, Hugh Grant, Jeremy Clarkson, Brian May, and a rotating cast of Premier League footballers all wandering around before lights out. None of that happens by accident. It's the byproduct of a decade of deliberate positioning, Drive to Survive turning drivers into recognizable characters, Lewis Hamilton's move to Ferrari giving British fans a rooting interest wrapped in Italian red, and a championship fight tight enough that Antonelli, Russell, and Hamilton are now separated by 32 points with more than a third of the season still to run.
There's a financial angle to a record crowd that's easy to skip past amid the celebrity spotting. Grandstand seats, hospitality packages, and paddock club access make race week Silverstone's single biggest revenue event of the year, and promoters don't publish attendance totals purely for bragging rights. They're effectively an annual earnings report for the venue, one that circuits use internally to justify grandstand expansions and, eventually, to defend the nex
4 months ago
The 2026 PWHL Draft took place on June 17 in Detroit, marking the first draft for the four expansion teams the league announced in May.
The new teams are located in Detroit, Hamilton, Las Vegas and San Jose. Going into the league's fourth season, it will now have 12 teams. Its size has doubled since debuting with the inaugural six teams in 2023.
This rapid expansion is a remarkable reflection of the PWHL's success in growing both hockey and women's sports. However, it also highlights several major internal issues that the league should resolve before considering additional expansion in the coming years.
With two back-to-back expansions, some teams have lost many players for two consecutive seasons. These losses hinder teams from forming a cohesive on-ice identity and chemistry. They also deliver disappointment to fans of the existing teams yet again in the league's short history. How can new fans connect to teams that have never been consistent from their inception?
Teams cannot grow into being strong and unified if they must rebuild every season. The league should invest more in the teams it already has rather than focusing on forming new ones.
The new teams are located in Detroit, Hamilton, Las Vegas and San Jose. Going into the league's fourth season, it will now have 12 teams. Its size has doubled since debuting with the inaugural six teams in 2023.
This rapid expansion is a remarkable reflection of the PWHL's success in growing both hockey and women's sports. However, it also highlights several major internal issues that the league should resolve before considering additional expansion in the coming years.
With two back-to-back expansions, some teams have lost many players for two consecutive seasons. These losses hinder teams from forming a cohesive on-ice identity and chemistry. They also deliver disappointment to fans of the existing teams yet again in the league's short history. How can new fans connect to teams that have never been consistent from their inception?
Teams cannot grow into being strong and unified if they must rebuild every season. The league should invest more in the teams it already has rather than focusing on forming new ones.
4 months ago
The iShares Russell 2000 Growth ETF (NYSEMKT:IWO) offers massive scale and liquidity, while the iShares Morningstar Small-Cap Growth ETF (NYSEMKT:ISCG) provides a much cheaper fee structure for small-cap growth exposure.
Small-cap growth stocks are often sought for their potential to outperform broader markets during economic expansions, though they typically carry higher volatility. Both iShares' Russell 2000 Growth ETF and Morningstar Small-Cap Growth ETF provide exposure to this aggressive equity segment, yet they differ significantly in their fee structures, liquidity, and the specific indexes they use to identify growth characteristics.
Metric
ISCG
IWO
Small-cap growth stocks are often sought for their potential to outperform broader markets during economic expansions, though they typically carry higher volatility. Both iShares' Russell 2000 Growth ETF and Morningstar Small-Cap Growth ETF provide exposure to this aggressive equity segment, yet they differ significantly in their fee structures, liquidity, and the specific indexes they use to identify growth characteristics.
Metric
ISCG
IWO
4 months ago
The 2026 World Cup group stage pulled more fans into stadiums than any full tournament in the competition’s entire history.
FIFA released its official group-stage figures on Sunday, a day after the opening round wrapped up. The governing body counted 4.6 million spectators across the 72 matches staged in 16 host cities in Canada, Mexico and the United States.
The 17 days of action drew supporters from 210 countries and territories. In doing so, the first 48-team World Cup blew past an attendance record that had stood since the United States last hosted back in 1994.
That benchmark had survived more than three decades and two tournament expansions.
The headline figure is 4,644,549 — the people who passed through the turnstiles across the group phase. FIFA says that filled 99.7% of all available seats, for an average crowd of 64,508 per match.
FIFA released its official group-stage figures on Sunday, a day after the opening round wrapped up. The governing body counted 4.6 million spectators across the 72 matches staged in 16 host cities in Canada, Mexico and the United States.
The 17 days of action drew supporters from 210 countries and territories. In doing so, the first 48-team World Cup blew past an attendance record that had stood since the United States last hosted back in 1994.
That benchmark had survived more than three decades and two tournament expansions.
The headline figure is 4,644,549 — the people who passed through the turnstiles across the group phase. FIFA says that filled 99.7% of all available seats, for an average crowd of 64,508 per match.
4 months ago
With an annual dividend yield of 2.13%, Union Pacific Corporation (NYSE:UNP) is included among the 12 Best S&P 500 Stocks to Buy for Dividends.
Union Pacific Corporation (NYSE:UNP) connects 23 western US states, providing efficient railroad transportation, freight shipping, logistics, and rail safety services.
Union Pacific Corporation (NYSE:UNP) held an investor conference last week in which the company reiterated its key financial and operating **** umptions for the year. The firm is expecting inflation, excluding fuel, for the year to be around 4% compared with 2025, while depreciation is forecasted to rise by 4% YoY. Moreover, it is projecting merger-related costs of about $25 million per quarter and a tax rate of approximately 24%.
Union Pacific Corporation (NYSE:UNP) also reaffirmed its capital expenditure target of about $3.3 billion for 2026. The investment will go toward infrastructure replacement, capacity and commercial facilities, technology investments, and locomotive and equipment upgrades.
Union Pacific management also outlined the company's volume outlook across business segments for the year. The railroad operator remains optimistic in areas such as grain and grain products exports, supported by soybeans and renewable fuels policy clarity. Moreover, it is expecting growth in industrial chemicals and plastics tied to new business wins and plant expansions.
Union Pacific Corporation (NYSE:UNP) connects 23 western US states, providing efficient railroad transportation, freight shipping, logistics, and rail safety services.
Union Pacific Corporation (NYSE:UNP) held an investor conference last week in which the company reiterated its key financial and operating **** umptions for the year. The firm is expecting inflation, excluding fuel, for the year to be around 4% compared with 2025, while depreciation is forecasted to rise by 4% YoY. Moreover, it is projecting merger-related costs of about $25 million per quarter and a tax rate of approximately 24%.
Union Pacific Corporation (NYSE:UNP) also reaffirmed its capital expenditure target of about $3.3 billion for 2026. The investment will go toward infrastructure replacement, capacity and commercial facilities, technology investments, and locomotive and equipment upgrades.
Union Pacific management also outlined the company's volume outlook across business segments for the year. The railroad operator remains optimistic in areas such as grain and grain products exports, supported by soybeans and renewable fuels policy clarity. Moreover, it is expecting growth in industrial chemicals and plastics tied to new business wins and plant expansions.
4 months ago
Remitly Global Inc. (NASDAQ:RELY) is one of the 10 best payment processing stocks to buy now. The company's expansions into new geographies, through strategic integrations, support a favorable stance around the stock. On May 27, Remitly Global Inc. (NASDAQ:RELY) announced the integration of Bre-B, Colombia's national instant payment system backed by Banco de la República, into its remittance network.
With just the recipient's phone number, email address, or national ID connected to a partner bank account or digital wallet, customers can now send money to Colombia instantly and around the clock. In just 6 months, Bre-B has handled over 600 million transactions and accumulated over 34 million registered users, according to Banco de la República.
Copyright: sifotography / 123RF Stock Photo
Within 6 weeks of its inception, the remittance platform's Bre-B transaction volume tripled. Sending money is an act of care, according to Remitly Vice President Nick Moiseff, and this integration gives senders and recipients ******* urance that money will arrive promptly, consistently, and transparently.
The Bre-B system has also expanded the company's current payout network in Colombia, which already consists of cash pickup services, conventional bank deposits, and mobile wallets like Nequi, Daviplata, and Bancolombia A La Mano.
With just the recipient's phone number, email address, or national ID connected to a partner bank account or digital wallet, customers can now send money to Colombia instantly and around the clock. In just 6 months, Bre-B has handled over 600 million transactions and accumulated over 34 million registered users, according to Banco de la República.
Copyright: sifotography / 123RF Stock Photo
Within 6 weeks of its inception, the remittance platform's Bre-B transaction volume tripled. Sending money is an act of care, according to Remitly Vice President Nick Moiseff, and this integration gives senders and recipients ******* urance that money will arrive promptly, consistently, and transparently.
The Bre-B system has also expanded the company's current payout network in Colombia, which already consists of cash pickup services, conventional bank deposits, and mobile wallets like Nequi, Daviplata, and Bancolombia A La Mano.
4 months ago
Remitly Global Inc. (NASDAQ:RELY) is one of the 10 best payment processing stocks to buy now. The company's expansions into new geographies, through strategic integrations, support a favorable stance around the stock. On May 27, Remitly Global Inc. (NASDAQ:RELY) announced the integration of Bre-B, Colombia's national instant payment system backed by Banco de la República, into its remittance network.
With just the recipient's phone number, email address, or national ID connected to a partner bank account or digital wallet, customers can now send money to Colombia instantly and around the clock. In just 6 months, Bre-B has handled over 600 million transactions and accumulated over 34 million registered users, according to Banco de la República.
Copyright: sifotography / 123RF Stock Photo
Within 6 weeks of its inception, the remittance platform's Bre-B transaction volume tripled. Sending money is an act of care, according to Remitly Vice President Nick Moiseff, and this integration gives senders and recipients ***** urance that money will arrive promptly, consistently, and transparently.
The Bre-B system has also expanded the company's current payout network in Colombia, which already consists of cash pickup services, conventional bank deposits, and mobile wallets like Nequi, Daviplata, and Bancolombia A La Mano.
With just the recipient's phone number, email address, or national ID connected to a partner bank account or digital wallet, customers can now send money to Colombia instantly and around the clock. In just 6 months, Bre-B has handled over 600 million transactions and accumulated over 34 million registered users, according to Banco de la República.
Copyright: sifotography / 123RF Stock Photo
Within 6 weeks of its inception, the remittance platform's Bre-B transaction volume tripled. Sending money is an act of care, according to Remitly Vice President Nick Moiseff, and this integration gives senders and recipients ***** urance that money will arrive promptly, consistently, and transparently.
The Bre-B system has also expanded the company's current payout network in Colombia, which already consists of cash pickup services, conventional bank deposits, and mobile wallets like Nequi, Daviplata, and Bancolombia A La Mano.
5 months ago
UFP Industries Inc (NASDAQ:UFPI) is one of the best land and timber stocks to buy now. ******* ysts expect the stock to jump more than 29% from its current level.
UFP Industries Inc (NASDAQ:UFPI)’s Q1 2026 results, released on April 29, showed revenue slipped 8% YoY to $1.46 billion due to weak prices and unit sales. EPS of $0.89 declined from $1.30 a year ago. Earnings were impacted by higher fuel costs, adverse weather, and other factors. The company said rising input costs accounted for more than half of the decline in profit in the quarter.
While Q1 2026 did not go well for UFP Industries, the management believes the current headwinds will be temporary. The management further noted progress in managing costs and executing on strategies to position the company for long-term success.
On cost controls, the company says it is on track to deliver at least $25 million in cost outs by the end of 2026. At the same time, it is structurally lowering its cost base. On growth strategies, the management mentioned combining organic expansions with disciplined acquisitions, strengthening core businesses, and launching innovative products.
Michigan-based UFP Industries Inc (NASDAQ:UFPI) converts lumber into various value-added products. It manufactures, distributes, and sells a variety of products used in construction, packaging, and other industrial applications. The company operates three main business segments.
UFP Industries Inc (NASDAQ:UFPI)’s Q1 2026 results, released on April 29, showed revenue slipped 8% YoY to $1.46 billion due to weak prices and unit sales. EPS of $0.89 declined from $1.30 a year ago. Earnings were impacted by higher fuel costs, adverse weather, and other factors. The company said rising input costs accounted for more than half of the decline in profit in the quarter.
While Q1 2026 did not go well for UFP Industries, the management believes the current headwinds will be temporary. The management further noted progress in managing costs and executing on strategies to position the company for long-term success.
On cost controls, the company says it is on track to deliver at least $25 million in cost outs by the end of 2026. At the same time, it is structurally lowering its cost base. On growth strategies, the management mentioned combining organic expansions with disciplined acquisitions, strengthening core businesses, and launching innovative products.
Michigan-based UFP Industries Inc (NASDAQ:UFPI) converts lumber into various value-added products. It manufactures, distributes, and sells a variety of products used in construction, packaging, and other industrial applications. The company operates three main business segments.
10 months ago
Bitcoin mining equities are selling off again to start off 2026. If you’re one of those people searching “is bitcoin mining still profitable?”, you might want to think again.
Even as miners lock in massive Bitcoin mining infrastructure expansions, financing agreements, and AI-adjacent partnerships, stock prices continue to drift lower alongside Bitcoin’s sluggish price action.
hovered near $88,900 on Tuesday, up modestly on the day but still down roughly 2.8% month-over-month. That lack of momentum is bleeding directly into publicly traded miners, where equity investors remain far less forgi
Even as miners lock in massive Bitcoin mining infrastructure expansions, financing agreements, and AI-adjacent partnerships, stock prices continue to drift lower alongside Bitcoin’s sluggish price action.
hovered near $88,900 on Tuesday, up modestly on the day but still down roughly 2.8% month-over-month. That lack of momentum is bleeding directly into publicly traded miners, where equity investors remain far less forgi
